Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach

scientific article

Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/EURHEARTJ/EHR161
P932PMC publication ID3205477
P698PubMed publication ID21646229
P5875ResearchGate publication ID51196407

P50authorJeroen Joost BaxQ77085900
Martin Jan SchalijQ89053249
Lieselot van ErvenQ114403342
P2093author name stringSuzanne C Cannegieter
C Jan Willem Borleffs
Johannes B van Rees
Mihály K de Bie
Enno T van der Velde
Joep Thijssen
P2860cites workProphylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fractionQ28208692
Resumption of driving after life-threatening ventricular tachyarrhythmiaQ33146680
Syncope, driving recommendations, and clinical reality: survey of patientsQ33148460
Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock TherQ33151960
Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North AmericanQ33154785
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 GuiQ33156283
Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillatorsQ33156418
Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocksQ33157498
Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapyQ33158802
Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillatorQ33174543
Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of PQ33174830
Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictionsQ33175534
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failureQ34321811
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureQ34386004
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of CardioloQ34560910
Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE GroupQ40703058
Legal and ethical aspects of driving and working in patients with an implantable cardioverter defibrillatorQ40741733
Death at the wheel. A consideration of cardiovascular disease as a contributory factor to road accidents.Q43732246
Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impactQ43848349
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial InvestigatorsQ44086151
Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillatorQ44974110
Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillatorsQ47635686
Fits and other causes of loss of consciousness while driving.Q49016966
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarctionQ49171490
Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA studyQ50084690
Natural death while drivingQ50121383
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.Q50744359
Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) triaQ51447936
Implantable cardioverter defibrillators and fitness to drive.Q53667437
Time to first pulse after automatic implantable cardioverter defibrillator implantationQ68140057
Assessment of the cardiac patient for fitness to driveQ68182395
Implantable cardioverter defibrillators and fitness to driveQ72669638
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial InvestigatorsQ73280436
Assessment of the cardiac patient for fitness to drive: 1996 updateQ73434428
Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial InvestigatorsQ73884395
P433issue21
P921main subjectdefibrillatorQ1450682
P304page(s)2678-2687
P577publication date2011-06-05
P1433published inEuropean Heart JournalQ2286839
P1476titleDriving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach
P478volume32